Lessons From Novartis' $678M Speaker Program Settlement
Novartis Pharmaceuticals Corporation recently agreed to pay $678 million to settle False Claims Act litigation with the U.S. Department of Justice involving one of the most common industry marketing tactics: physician-led...To view the full article, register now.
Already a subscriber? Click here to view full article